Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
The EU wants to be able to protect itself, alone, from a potential attack from 2030, but defence SMEs have faced challenges ...
A pair of marine scientists at the University of Antwerp, in Belgium, working with a colleague from the University of Otago, ...
Successful initial administration and full enrollment in first-in-human LIBERATE-1â„¢ study of NPM-115 (exenatide implant) in ...
Driven by escalating water concerns, the point-of-use water treatment systems market is rapidly growing, as consumers ...
Coronary artery disease has long been understood through the paradigm of epicardial coronary artery obstruction, causing ...